**1. Business Performance:** Balaji Amines saw Q3FY26 consolidated revenue of ₹336 Cr (+4.9% YoY), with volumes up to 25,894 MT, reflecting stable operations.

However, 9MFY26 revenue slightly dipped 1.7% YoY to ₹1,051 Cr. **2. Growth Drivers or Strategy:** Focusing on high-value specialty chemicals, the company plans new DME, NMM, and improved ACN plants by FY26-27, funded internally.

Its subsidiary, Balaji Speciality Chemicals, has a ₹750 Cr expansion for products like HCN and EDTA, holding 'Mega Project' status. **3. Recent Developments:** A new Methyl Amines plant (Nov 2024), Electronic Grade DMC plant for EV batteries (May 2025), and a 6 MW solar power plant (Apr 2025) were recently commissioned.

The company maintains zero-debt standalone. **4. Key Financial Metrics:** Q3FY26 consolidated EBITDA rose 15.1% YoY to ₹62 Cr (18% margin), with PAT stable at ₹31 Cr.

9MFY26 EBITDA was ₹192 Cr, and PAT stood at ₹104 Cr. **5. Management Commentary / Outlook:** Management projects robust growth and healthy margins by leveraging new product opportunities and strong demand for key chemicals.